hydroxyindoleacetic acid has been researched along with trichostatin a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Fei, J; Huang, D; Huang, F; Huang, L; Huang, Y; Liu, J; Ma, Y; Suo, H; Tong, J; Wang, P; Wang, Z; Xu, J; Yu, M | 1 |
1 other study(ies) available for hydroxyindoleacetic acid and trichostatin a
| Article | Year |
|---|---|
NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Line, Tumor; Dopamine; Drug Evaluation, Preclinical; Epigenesis, Genetic; Histones; Humans; Hydroxamic Acids; Hydroxyindoleacetic Acid; Male; Mice, Knockout; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Repressor Proteins; Serotonin | 2015 |